Life ScienceCompany
AbbVie M&A Summary
AbbVie has acquired 13 companies, including 10 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
AbbVie’s largest acquisition to date was in 2019, when it acquired Allergan for $63.0B. It’s largest disclosed sale occurred in 2020, when it sold Rare Pediatric Disease Priority Review Voucher to United Therapeutics for $105M. AbbVie has acquired in 7 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
AbbVie Business Overview
Where is AbbVie headquartered?
AbbVie is headquartered in North Chicago, Illinois.
What is AbbVie’s revenue?
AbbVie disclosed revenue of 54,318M USD for 2023 and 58,054M USD for 2022.
How many employees does AbbVie have?
AbbVie has 50,000 employees.
What sector is AbbVie in?
AbbVie is a life science company.
When was AbbVie founded?
AbbVie was founded in 2012.
M&A Summary
-
M&A Total Activity14
- M&A Buy Activity13
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 2
- M&A Advisors 9
Unlimited Searches
